UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping

Oct.04.2024
UK Study: 5.1 Million E-Cigarette Users, Over 1 Million Non-Smokers Start Vaping
A UK study shows that there are 5.1 million e-cigarette users among people aged 16 and over, with the usage rate highest among the 16-24 age group at 15.8%. Over 1 million non-regular smokers have started using e-cigarettes, with usage increasing sevenfold over the past three years.

According to a recent report by The Guardian, research data shows that one in every ten people aged 16 and above in the UK is using e-cigarettes. The number of non-regular smokers in the UK who have started using e-cigarettes has increased sevenfold in three years, reaching 1 million. This has raised concerns among health experts.


Before 2021, the usage of e-cigarettes among non-regular adult smokers remained stable, with approximately 1 in 200 people, or about 133,000 individuals, using e-cigarettes. However, a study published in The Lancet Public Health indicates that by 2024, this proportion is projected to increase sharply to 1 in every 28 people, equating to 1.006 million individuals.


Data released this week by the Office for National Statistics in the UK reveals that there are a total of 5.1 million e-cigarette users aged 16 and over in the country. The age group with the highest e-cigarette usage rate is 16 to 24-year-olds, with a rate of 15.8%.


The study also found that the majority of e-cigarette users who had never smoked regularly are using e-cigarettes on a daily basis and for longer periods of time. This sharp increase is mainly driven by young people, with research showing that 14% of non-regular smokers aged 18 to 24 in the UK are now using e-cigarettes.


Researchers warn that the UK government's plans to ban disposable e-cigarettes may not fully address the issue, as some brands have already introduced reusable products. Experts suggest that reducing the appeal of e-cigarette products may require stricter regulations and laws.


Professor Jamie Brown from the Institute of Epidemiology and Health Care at University College London (UCL) believes that although measures to ban disposable e-cigarettes may not be enough to solve the problem, stricter regulations on the appearance, packaging, and marketing of products could be introduced. These measures are unlikely to reduce the effectiveness of e-cigarettes in smoking cessation. He points out that by 2023, the overall prevalence of e-cigarettes seems to be stabilizing, which may provide a reasonable basis for implementing these measures and assessing their effectiveness.


The study analyzed survey data from 153,073 adults in the UK between 2016 and 2024, of which 94,107 had never smoked regularly. The data showed that the proportion of non-smokers who used e-cigarettes increased from 0.5% in 2016-2020 to 3.5% by April 2024, surpassing 1 million people, with over half of them aged between 18 and 24.


Researchers also found that in recent years, the group of people who smoke irregularly tends to be younger, with an increase in the proportion of women. They are more likely to use disposable devices and high-concentration nicotine e-cigarette liquid, and mainly purchase products in supermarkets or convenience stores.


In a statement released by the Department of Health and Social Welfare in the UK, the department emphasized that although e-cigarettes can effectively help adults quit smoking, children and non-smoking adults should not use e-cigarettes. The department stated that the Tobacco and E-cigarette Act will protect future generations from the harms of tobacco and nicotine, save countless lives, and alleviate pressure on the national healthcare system.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24